Cargando…

Harnessing the Helminth Secretome for Therapeutic Immunomodulators

Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ditgen, Dana, Anandarajah, Emmanuela M., Meissner, Kamila A., Brattig, Norbert, Wrenger, Carsten, Liebau, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123613/
https://www.ncbi.nlm.nih.gov/pubmed/25133189
http://dx.doi.org/10.1155/2014/964350
_version_ 1782329520400891904
author Ditgen, Dana
Anandarajah, Emmanuela M.
Meissner, Kamila A.
Brattig, Norbert
Wrenger, Carsten
Liebau, Eva
author_facet Ditgen, Dana
Anandarajah, Emmanuela M.
Meissner, Kamila A.
Brattig, Norbert
Wrenger, Carsten
Liebau, Eva
author_sort Ditgen, Dana
collection PubMed
description Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survival depends on influencing and regulating the immune responses away from the mode of action most damaging to them. Immunologists have focused on the excretory and secretory products that are released by the helminths, since they can change the host environment by modulating the immune system. Here we give a brief overview of the helminth-associated immune response and the currently available helminth secretome data. We introduce some major secretome-derived immunomodulatory molecules and describe their potential mode of action. Finally, the applicability of helminth-derived therapeutic proteins in the treatment of allergic and autoimmune inflammatory disease is discussed.
format Online
Article
Text
id pubmed-4123613
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41236132014-08-17 Harnessing the Helminth Secretome for Therapeutic Immunomodulators Ditgen, Dana Anandarajah, Emmanuela M. Meissner, Kamila A. Brattig, Norbert Wrenger, Carsten Liebau, Eva Biomed Res Int Review Article Helminths are the largest and most complex pathogens to invade and live within the human body. Since they are not able to outpace the immune system by rapid antigen variation or faster cell division or retreat into protective niches not accessible to immune effector mechanisms, their long-term survival depends on influencing and regulating the immune responses away from the mode of action most damaging to them. Immunologists have focused on the excretory and secretory products that are released by the helminths, since they can change the host environment by modulating the immune system. Here we give a brief overview of the helminth-associated immune response and the currently available helminth secretome data. We introduce some major secretome-derived immunomodulatory molecules and describe their potential mode of action. Finally, the applicability of helminth-derived therapeutic proteins in the treatment of allergic and autoimmune inflammatory disease is discussed. Hindawi Publishing Corporation 2014 2014-07-15 /pmc/articles/PMC4123613/ /pubmed/25133189 http://dx.doi.org/10.1155/2014/964350 Text en Copyright © 2014 Dana Ditgen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Ditgen, Dana
Anandarajah, Emmanuela M.
Meissner, Kamila A.
Brattig, Norbert
Wrenger, Carsten
Liebau, Eva
Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title_full Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title_fullStr Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title_full_unstemmed Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title_short Harnessing the Helminth Secretome for Therapeutic Immunomodulators
title_sort harnessing the helminth secretome for therapeutic immunomodulators
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123613/
https://www.ncbi.nlm.nih.gov/pubmed/25133189
http://dx.doi.org/10.1155/2014/964350
work_keys_str_mv AT ditgendana harnessingthehelminthsecretomefortherapeuticimmunomodulators
AT anandarajahemmanuelam harnessingthehelminthsecretomefortherapeuticimmunomodulators
AT meissnerkamilaa harnessingthehelminthsecretomefortherapeuticimmunomodulators
AT brattignorbert harnessingthehelminthsecretomefortherapeuticimmunomodulators
AT wrengercarsten harnessingthehelminthsecretomefortherapeuticimmunomodulators
AT liebaueva harnessingthehelminthsecretomefortherapeuticimmunomodulators